Tirzepatide may help patients with obstructive sleep apnea and obesityTwo double-blind, randomized controlled trials show positive effects of tirzepatide, with or without concomitant use of positive airway pressure therapy. POLL: What is the biggest challenge Canada faces?See what your colleagues say. Take our weekly doctor poll. UBC researchers create oral insulin drops for diabetes The needle-free alternative is a mixture of insulin and a cell-penetrating peptide that's absorbed into the body after being put under the tongue. Ringing an alarm: Predicting osteoarthritis before the onset of pain, damage to joints The presence of certain proteins could act as an alarm signal announcing the disease before it reaches the acute phase. Nightmares could be an early warning sign of an autoimmune disease flare-up: new study Descriptions of flare-related nightmares in the study often involved being attacked, trapped, crushed or falling. Major weight loss doesn’t do much to ease gout in patients with obesity: study Current guidelines recommend weight loss to help manage gout, but a clinical trial conducted in Denmark brings that advice into question. Northern Ontario School of Medicine University appoints new president, CEO Family physician will take the leadership role. Meet the centenarians: Canada's oldest age group is also its fastest-growing Statistics Canada data show the country’s population of people aged at least 100 more than tripled between 2000 and 2023, up from 3,393 to 11,705. PTSA reps explore solutions to workforce challenges Forum encourages participants to find solutions in attracting and retaining workforce. Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea An outside expert cautioned in an editorial that more research will be needed to tell if the drug can be used as ‘a sole treatment’ for obstructive sleep apnea. First Previous 38 39 40 41 42 Next Last
